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• As several countries begin to exit various forms of COVID-19 “lockdown,” a simple 
epidemiological tool – Population Attributable Risk – can help guide decisions about specific exit 
policy options, by quantifying the proportion of “serious” (hospitalised) COVID-19 cases likely 
attributable to various combinations of individual risk factors at the population level, such as age 
alone, versus age combined with the presence of any chronic disease/risk factor. 
• Using recent COVID-19 hospitalisation data from a large hospital network, and current Scottish 
population age structure and risk-factor prevalences, we show that the likely impact on adult 
hospitalisations would be very similar (an approximate halving, compared to full lockdown exit 
for all adults) for the most “moderate” and yet reasonably effective options for continued 
lockdown: continuing to restrict the social contacts of all persons over 65, compared to all 
persons over 50 with any chronic disease/risk factor. 
• Other considerations are therefore of critical importance to this decision, such as the equity and 
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Many countries are now struggling to identify optimal exit strategies from the COVID-19 pandemic 
lockdown. As with previous pandemics, responding to COVID-19 has been characterised by ‘uncertainty, 
high potential loss, time pressure, and competing values’ - all of which are a challenges to adopting an 
evidence based policy response.1, 2 Weible, Nohrstedt 3 and Xu and Basu 4 have retrospectively reviewed 
how decisions have been made in various countries, with various degrees of success. However, watching 
and waiting for the optimal approach to be identified in another country is not a viable option and 
therefore various decision-making approaches have been advocated in the literature.  These include 
principalism5, 6, risk-based decision-making (RBDM)7, experimentation8 and analytic modelling9-11. Within 
each of these approaches data are important, including understanding the limitations of the available 
data when ideal data are not available.12 
 
As more data about the pandemic becomes available, a variety of methods are being applied to 
understanding what has happened and predicting what might happen next. Stedman, Davies 13 and 
colleagues used trend analysis to analyse the state of the pandemic in the UK, with the intent of 
informing future policy actions. In the city of Honghu in Hubei, China cloud-based systems were used to 
monitor the pandemic.14 Tsay, Lejarza 15 and colleagues applied more traditional infectious disease 
models compartmentalising: susceptible, exposed, infectious, recovered (SEIR) people in data from the 
USA, Germany, Italy and Spain. Li, Tang 16 and colleagues extended the SEIR model to model the impact 
of mass influenza vaccination and public health interventions. The computational power available today 
means that these types of models can be developed and run quickly. However, as Rhodes and Lancaster 
10 discuss, the multitude of models can become problematic, complicating and confusing rather than 
supporting evidence-based decision making. Subsequently, there is a need for more easily understood 
and transparent models, especially when they can help decide between competing interests.11 
 
We describe a traditional and remarkably simple epidemiological tool, rarely applied to infectious 
diseases, which can be used to quickly estimate and compare the potential main benefits and “costs” 
(i.e. negative consequences) of various exit strategies. That tool is Levin’s Population Attributable Risk 
(PAR)17 – the proportion of disease burden which is attributable to any given risk factor, such as age or 
the presence of one or more chronic diseases, in the case of COVID-19. 
 
𝑃𝐴𝑅 =  
𝑝(𝑅𝑅 − 1)
1 + 𝑝(𝑅𝑅 − 1)
 
 
Where p is the proportion of the population exposed to the risk factor, and RR is the relative risk of the 
outcome related to the risk factor. 
 
We demonstrate how this method can be easily applied to compare two exit strategies: 
A. continuing lockdown for all older adults (based on two age cut-offs: 50+ and 65+); 
B. continuing lockdown only for adults with one or more chronic disease risk factor/condition 
(CDRF), also stratified by these same age-groups, compared to continuing lockdown for all adults 
20 to 49 years of age. 
 
Methods 
These calculations are applied to Scotland in May 2020 (when lockdown relaxation measures were just 
beginning to be considered) using data readily available at that time: 




• recent Scottish Health Survey19 prevalence estimates for common chronic conditions known to 
increase the risk of severe COVID-19 (CDRFs): “any cardiovascular disease or diabetes”; obesity; 
asthma or COPD (Table 2.3 of the Survey report); and 
• early-pandemic (March 2020) USA age-specific rates of COVID-19 hospitalisation20, as well as 
characteristics of hospitalised cases, in terms of both age and CDRF status21. 
 
We chose COVID-19-related hospitalisation as our outcome because hospitalisation is both serious for 
patients and costly to societ;y there are also fewer threats to the validity of these data than case 
counts/incidence rates in settings with incomplete and rapidly changing testing regimens –as is typical of 
many COVID-19-affected countries to date. The US COVID-19 admission rate data were collected from 
the large COVIDNET hospital network, with statistically stable admission rates through to April 25th. 
Since only relative risks will be used, these absolute population-based admission rates need not be 
generalisable beyond that US setting; they just need to be based on consistent admitting practices over 
time, by age group and risk-factor status, which is more credible inside a single set of hospitals so early 
in the pandemic in the USA. It is appreciated that some features of the US pandemic during this period 
were different from those that pertain to the subsequent few months' situation in the UK/Scotland. 
However, we believe that the probable continuing low cumulative incidence of COVID-19 infections in 
the UK (very few antibody-survey estimates have been above 10% of the general national population, 
through to early May22, 23) means that options for exiting lockdown at that time in the UK were likely to 
carry similar relative risks, by age and CDRF-status, to the remarkably stable age-specific admission rates 
over time seen in the USA COVIDNET network through to mid-April. This is especially credible because 
that was during a period when suitable hospital beds in most of that country were not yet filled with 
cases, and strong lockdown measures were not yet in place (only 32 states had even started lockdown 
by the end of March).24 
 
Scenario A – Age-based restrictions (Table 1) 
The first step in calculating PAR based solely on age is to calculate the age-specific relative risks (RR) of 
COVID-19 hospitalisation. These relative risks based on the COVIDNET data are shown in Table 1 (Step 1) 
alongside the absolute hospitalisation rates from which they were calculated.20 Next, we tabulate the 
proportion of the general population (Scotland, 2011 census) in each of the age groups: p (Step 2).18 
Finally, we use the figures from the first two steps to calculate the PARs for each of the three age-
groups’ using the equation given above (Step 3). The resulting PARs are the proportion of hospitalisation 
of people aged 50-64 or over 65 years out of the total number of hospitalisations. Therefore, the PARs 
give an indication of the potential reduction in COVID-19 hospitalisation from of continuing lockdown 
for: i) those over 50; ii) those over 65. These results can be interpreted as indicating that continuing 
effective lockdown for only those age 65+ would theoretically reduce the total adult COVID-19 
hospitalisations by 50.6% and affect the quality of life of about one in five of the Scottish population, the 
vast majority of whom are retired. Continuing lockdown for those over 50, on the other hand, while 
massively reducing adult hospitalisations by (30.6+50.6)=81.2%, would interfere with the lives of 
(21.0%+19.4%) = 40.4% of the entire Scottish population, of whom more than half are below age 65, 
with potentially significant economic effects.  
 
Scenario B – Age- and co-morbidity-based restrictions (Table 2) 
In this scenario we are estimating the population risk attributable to the combination of two risk factors; 
age and health, represented by the presence of one or more CDRFs. The American Geriatrics Society 
(AGS) has explicitly called for comorbidities to be considered in policy decision, avoiding solely age-
based criteria.25 Subsequently, the steps are slightly different. First, we estimate the relative risk (RR) of 




each of the three age groups (Table 2, Step 1). A rapid way to approximate these RRs is to perform a 
case-control analysis based on CDC Atlanta’s summary of the proportion of a large series of COVID-NET 
hospitalisations21, in all of March 2020, who have at least one CDRF, compared to “controls” of the same 
age-group in the general population (from Scottish Health Survey19); to reduce confounding by age, use 
age-stratification. Note the paradoxical non-linearity of the relationship between RR and age, indicating 
a strong effect of co-morbidity in the youngest age-group, and also in the elderly – effectively an 
interaction effect. Next, we tabulate the proportion (p) of each of each adult Scottish age-group who 
have at least one of the following CDRFs: heart disease; COPD or asthma; diabetes; obesity; 
hypertension (Step 2). Some interpolation is required since the Scottish Health Survey19 reports 
prevalence separately for these common (self-reported) chronic conditions. To prevent double-counting 
of persons with more than one condition, the estimates in Table 2 are totals of: the full age-specific 
prevalence of “any CVD/diabetes” added to half of each of the age-specific prevalences of the other 
three conditions. Better estimates can be readily derived from co-morbidity studies in primary care. As 
in scenario A we then calculate the analogous PARs for each of the three age-specific sub-populations’ 
members with at least one CDRF (Step 3), modelling a policy of continuing lockdown only for that high-
risk group of adults, across the three age-strata, compared to no restrictions for that sub-population. 
The PARs calculated in Step 3 are the proportion of admissions in each age group attributable to having 
one or more CDRF. Therefore, to estimate the overall population impact we need weight the PARs by 
the proportion of admissions from each age group. This forth step is achieved by weighting these PARs 
across the three age-strata, by the proportion of US COVID-NET adult admissions20, 21 in each age group 
(cf. Step 3), giving the overall PARs shown in Table 2. 
 
This analysis of scenario B tells us that restricting the activities of persons with at least one CDRF, in all 
three adult age-groups, should reduce the overall COVID-19 hospitalisation rate by over three-quarters 
(compared to no relaxation of any restrictions for any adults), but at a very high “cost” of interfering in 
the lives of about 30% of 20-to-49-year-olds (a very large group, demographically speaking), 55% of 50-
to-64-year olds, and 64% of those age 65+ (cf. Step 4 above) – with the added concern that the two 
younger age groups are typically active in the labour market. Alternatively, by restricting the activity of 
those with CDRFs over 50, we could expect to reduce the hospitalisation rate by 57% (20.7% +36.3%), by 
interfering in the lives of the same proportions – 55% and 64% -- of those 50-64 and 65+ years of age, 
respectively. Since these persons are typically already aware of their CDRF status, their willingness to 
continue lockdown may be higher than for restrictions based on age alone, in order to minimise the 
personal risk based on their medical conditions.  
 
Conclusion 
As shown in Table 3, all five policy options are less than ideal, with only two carrying reasonable 
benefits, in terms of substantially reduced COVID-19 hospitalisations, without removing large numbers 
of people from the labour force: policies #2 and #4. There is not much to choose – in terms of 
epidemiologically estimated reductions in COVID-19 hospitalisations -- between restricting the activities 
of all persons over age 65, compared to restricting all persons over age 50 with CDRFs. However, the 
economic effects of the former policy would be much less than those of the latter, since the latter would 
affect a significant proportion of the active labour force; advocates for the elderly, on the other hand, 
are likely to be concerned about the “discriminatory nature” of purely age-based restrictions.25 Policy 
options #1 and #3 would prevent a substantially larger proportion of future COVID-19 admissions – but 
only by continuing to lockdown much larger numbers of adults – almost half the entire adult population 






We recognise that there are multiple other factors that governments need to consider, when assessing 
the options for easing the lockdown, including indirect effects on transmission dynamics, and the 
varying likelihoods of being able to work from home in these different sub-populations. Yet, using only 
publicly available data it is possible through calculating Population Attributable Risk to gain an insight 
into the trade-off between protecting the public and maintaining the economy.  Furthermore, compared 
to the mathematical models being used to model the pandemic, the arithmetic necessary to calculate 
Population Attributable Risk can be quickly carried out using any computer or calculator.  Therefore, we 
believe that Population Attributable Risk is a relatively simple and transparent tool that can be used to 
provide useful data to quickly and easily compare the potential benefits, and crude societal “costs” 
(adverse consequences) of various exit policy options from the COVID-19 lockdown. 
 
Table 1 – Calculating the population attributable risk related to age-based restrictions 






(per 100,000)4  
Relative 
risk 
Percent of Scottish 
Population in 20202 
Population Attributable 
Risk 
20*-49 22.6 1 
(reference) 
38.8% Reference group (lowest 
adult admission rate) 
50-64 69.3 3.1 21.0% 30.6% 
65+ 142.7 6.3 19.4% 50.6% 
* Note that the COVIDNET tabulation of cumulative hospitalisation rates  (per 100,000 population) for the 
youngest adult age group includes 18 and 19 year-olds, whereas all the other statistics used here include only 
those 20+ years of age; we have ignored this discrepancy, noting that COVID-19 hospitalisation rates at ages 18 
and 19 are trivially small. 
 
Table 2 – Calculating the population attributable risk related to age- and condition-based restrictions 
 Step 1 – Calculate Odds Ratios 
as an approximation of RR 
Step 2 – 
Calculate p 
Step 3 – 
Calculate 
PAR 
Step 4 – Weight the PARs 




























20-49 85% 30% 13.2 30% 78.5% 24.9% 19.7% 
50-64 85% 55% 4.6 55% 66.4% 31.3% 20.7% 
65+ 94% 64% 8.8 64% 83.3% 43.7% 36.3% 













Table 3 – Summary of the potential benefits (reduced COVID-19 hospitalisations) compared to the 
proportion of the population required to maintain lockdown for the policy options examined 
Policy Scenario Proportion of adult 
hospitalisations 
reduced 
Proportion of adult 
population affected 
A. Age-based   
 1. Restrict all persons over age 50 81% 40% 
 2. Restrict only persons over age 65 51% 19% 
B. Age- and co-Morbidity-Based   
 3. Restrict adults of all ages with CDRFs 77% 45% 
 4. Restrict all those with CDRFs over age 50 57% 21%* 
 5. Restrict all those with CRDFs over age 65 36% 11%* 
*These are the age-group-specific prevalences of one or more CDRFs in the most recent Scottish Health Survey, 
calculated as population-weight weighted averages of the prevalences in narrower age-bands 
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